SOM Biotech attends the Invest Securities Biomed Event on January 28th in Paris.
Raul Insa – CEO of SOM Biotech – participates in “one to one” meetings with international institutional investors. Therefore, according to Dr. Insa: “we will have the opportunity to share with qualified investors SOM´s future strategic growth plan. Certainly, we understand, that after having successfully achieved major milestones in our pipeline development, SOM Biotech has strengthened its positioning as a leading drug re-innovation company with a validated and highly effective AI-based proprietary technology – SOMAIPRO. However, our growth strategy is based not only on our competitive technology but also on our robust preclinical pipeline and our value creation approach which guides our asset selection, our partnering strategy, and our business focus”.
The Biomed Event event is one of the most relevant events for European biotech companies to meet with qualified investors in life science companies. Invest Securities are organizers of Biomed event, it is an independent brokerage company of Allinvest, a leading financial company headquartered in Paris.
You can find more information about the event here. If you want to meet SOM Biotech at Biomed Event, you can contact us here.